Funding for this research was provided by:
Nordic Bioscience A/S
Received: 29 June 2020
Accepted: 24 November 2020
First Online: 7 January 2021
Ethics approval and consent to participate
: The AMBITION study (NCT00109408) was approved by the ethics committee at each participating institution (in USA, Canada and Israel) and was conducted in accordance with the principles of good clinical practice and according to the Declaration of Helsinki. All patients included provided written, informed consent before inclusion in the study.
: Not applicable.
: Anne C. Bay-Jensen (ACBJ), Morten Karsdal (MK), Anne Siebuhr (ASO) and Samra Sardar (SSA) are full-time employees and/or shareholders at Nordic Bioscience. Patryk Drobinski (PAD) is a full-time employee at University of Copenhagen. PAD has no disclosures and no competing interests. None of the authors received any kind of financial benefits or other bonuses for the work described in this manuscript.